Clinical Trial Update: A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of dideoxycytidine (ddC) and zidovudine (AZT) in HIV-infected children previously treated with AZT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dideoxycytidine (zalcitabine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED